Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-05-19 @ 1:01 PM
Study NCT ID:
NCT04675333
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-03
First Post:
2020-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
Sponsor:
Organization: